Evidence map›Paper›PMID 17005955›Full record

ArticleThe New England journal of medicine2006

Sentinel-node biopsy in melanoma.

Charles M Balch, Natale Cascinelli

Abstract readCommentEditorial
PubMed Publisher
In one paragraph

Article in The New England journal of medicine, 2006. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Trial
  3. Lymphatic mapping and sentinel lymph node biopsy in women with squamous cell carcinoma of the vulva: a gynecologic oncology group study.Journal of clinical oncology : official journal of the American Society of Clinical Oncology · 2012
    Trial
  4. Article
  5. Article
  6. Article
  7. Article
  8. Lymphatic invasion and angiotropism in primary cutaneous melanoma.Laboratory investigation; a journal of technical methods and pathology · 2017
    Article
  9. Lymphatic invasion as a prognostic biomarker in primary cutaneous melanoma.Methods in molecular biology (Clifton, N.J.) · 2014
    Article
  10. Article
  11. Article
  12. Multivariate analysis of prognostic factors among 2,313 patients with stage III melanoma: comparison of nodal micrometastases versus macrometastases.Journal of clinical oncology : official journal of the American Society of Clinical Oncology · 2010
    Article
  13. Final version of 2009 AJCC melanoma staging and classification.Journal of clinical oncology : official journal of the American Society of Clinical Oncology · 2009
    Article
  14. The rationale for sentinel-node biopsy in primary melanoma.Nature clinical practice. Oncology · 2008
    Article
  15. Article
  16. What's wrong with sentinel node mapping in colon cancer?World journal of gastroenterology · 2007
    Review
  17. Review
  18. Article
  19. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

2 authors.

Charles M Balch
Natale Cascinelli

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Sentinel Lymph Node BiopsyHumansLymphatic MetastasisLymph NodesMelanomaNeoplasm StagingPrognosisSkin NeoplasmsSurvival Rate

Identifiers

PMID17005955

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.